Mediwatch Newsletter 2012 Q1
Transcription
Mediwatch Newsletter 2012 Q1
Ultrasound Urodynamics Biochemistry Mediwatch Newsletter Q1 2012 Providing Complete Pelvic Floor Diagnostic Solutions Mediwatch USA Inc 1501 Northpoint Parkway - Suite 103 West Palm Beach - FL 33407 - USA Tel: 1-888-471-2611 - Fax: 1-866-871-8262 E-mail: [email protected] Mediwatch UK Ltd Lumonics House - Valley Drive - Rugby CV21 1TQ - UK Tel: +44 (0) 1788 547888 - Fax: +44 (0) 1788 536434 E-mail: [email protected] www.mediwatch.com Staff changes in the UK: • Mark Hughes has joined as the CFO of Mediwatch Plc, based in the UK. Mr Hughes is a well qualified & experienced CFO, and an expert in financial and cost control. He has a broad experience having been at CFO / Finance Director level for over 25 years. For the last 11 years he has been an interim manager working internationally mainly at CFO level in industries such as IT consultancy, manufacturing, forestry, technology and healthcare equipment. Mr Hughes is a fellow of The Institute of Chartered Accountants in England and Wales, a member of the Institute of Directors, and has an MBA from the University of Warwick with an honors degree in Banking and International Finance. UK - PSAwatch: • The BMI hospital group in London has been using the PSAwatch system to provide free PSA tests for patients. The sessions are oversubscribed in some areas, showing the need for point of care PSA tests in the UK. • Additional results have been released from the European Randomised Study of Screening for Prostate Cancer (http://media.erspc-media.org/), showing a 29% drop in mortality due to prostate cancer in men who undergo PSA testing. • The Graham Fulford Trust is continuing their charitable PSA testing events across the UK, now using the PSAwatch system to replace their original laboratory testing method. They have found that the portability and speed of the PSAwatch system are combined with an accuracy that matches laboratory systems. • Spire Group, another private healthcare organisation, now has had a fourth successful PSAwatch testing session in the Windsor area. 2 Mediwatch Plc Newsletter Q1 2012 mediwatch.com UK - Sales • This year Mediwatch UK is planning to attend the UKCS exhibition in Liverpool, the ACA & BAUN meetings in Brighton, and the BAUS national meeting in Glasgow. • Liverpool Women’s hospital has invested in the simplicity of Sensic, placing an order for three complete Clinic systems. • Mediwatch’s presence in the UK market is being further enhanced with with two new sales representatives starting in March and May for London and the surrounding region, which will enable the team to spend more time on the new Gastroenterology and Neurophysiology product lines. Global: • Mediwatch has been approached by another major international pharmaceutical company to use Mediwatch equipment in a global trial. Middle East: • Mediwatch exhibited at the Arab Health show, one of the largest medical exhibitions in the world, in Dubai in January 2012, meeting physicians from across the region in conjunction with local distributors. • Several orders for capital systems were gained after the show in the UAE and Saudi Arabia, as well as the opportunity to run trials for PSAwatch in the UAE. 3 Mediwatch Plc Newsletter Q4 2011 mediwatch.com Europe: • Mediwatch exhibited at the European Association of Urologists annual congress (EAU) in Paris, demonstrating the complete product line. This was a great meeting with a large number of leads to generate sales for the Mediwatch distributors across Europe. • Additional Mediwatch distributors across Europe are in negotiations to now market PSAwatch. • The PSAwatch trial in France has now been completed, and the Mediwatch distributor has formed a new company to concentrate on marketing PSAwatch & urodynamics. Asia: • The president of MC Medical, the Mediwatch distributor in Japan, came with a delegation to visit the Mediwatch head office in Rugby to create a closer relationship. As a showing of respect and friendship a presentation was made to them of a rugby ball signed by Martin Johnson, captain of England’s World Cup winning team, while MC Medical presented a set of Japanese calligraphy pens to Mediwatch. This important meeting has created a stronger working relationship in the future for our new range of products in this key Asian market. 4 Mediwatch Plc Newsletter Q1 2012 mediwatch.com USA: • So far this year Mediwatch has attended a total of 7 conferences in the USA, including meetings for colorectal surgeons, urology nurses, urologists, urogynecologists and general gynecologists. • This year Mediwatch is making a strong push to the female urology & urogynecology markets, identifying them as key targets for growth in the future. As part of this marketing effort Mediwatch will be exhibiting at ACOG, the annual OB-GYN medical conference (in San Diego in May) for the first time. The booth has been redesigned for these shows to focus on Mobilewatch. • Mediwatch has run two nurse training courses on urodynamics in California and Florida this year. • In May Mediwatch will be attending the AUA in Atlanta Georgia, the major annual medical conference for urologists. The booth is redesigned with focused areas for Bladder Scanners and Mobilewatch. There is always a large international attendance at the AUA, especially from Latin America, which will provide valuable leads to the new Mediwatch distributors there. • In an effort to increase capital sales, 4 Independent Representatives were re-trained with advanced training, and 18 new Independent Representatives went through initial training. Mediwatch issued new Independent Representative agreements that offer an expanded and more competitive compensation package. • The Mobilewatch online portal is now being used by customers to book their mobile testing services and download results. • Mediwatch USA entered into synergistic marketing relationships with iON My Catheter and Uroval to offer Direct to Patient Catheter Delivery and Bulbocavernosus Testing Equipment to Physicians, respectively. 5 Mediwatch Plc Newsletter Q1 2012 mediwatch.com Latin America: • This quarter Mediwatch signed agreements with distributors in Costa Rica and Peru, and held discussions with potential new distributors in Brazil, Argentina, and Venezuala. Pedro Medina has begun visiting these distributors. • Mediwatch is planning to initially enter the Latin American Market with PSAwatch, the new Tablet Portaflow Scanner, and the next generation Portascan+. Future product registrations are expected to be catheters, Clinic System, and Uroval. Staff changes in the USA: Pedro Medina has joined as USA Latin American Regional Sales Manager. He has more than twenty years of Latin America medical device sales and distributor management under his belt. He brings with him relationships with over 40 Latin American distributors (many of them full service distributors). He also has a very good understanding and knowledge of the marketplace in each country and the regulation needed. • Pedro Medina will attend Hospitalar in Brazil in May, displaying the Mediwatch equipment range as part of the US pavilion. He will be looking for new dealers and potential joint relationships across Latin America. Canada: • Mediwatch signed two new distributors in Canada, and have been working on gaining registration approvals for several new products. • Orders have been taken in Canada for a bulk shipment of Urodyn+ flowmeters, while tenders for Portascan+ bladder scanners and Sensic urodynamic systems are in progress. • Mediwatch Regulatory has filed amendments to existing Health Canada registrations to expand the Mediwatch offering in Canada to include the Evolution, Clinic, Encompass, Portascan+ and Urodyn+ systems. Mediwatch Regulatory is in the process of registering PSAwatch in Canada. 6 Mediwatch Plc Newsletter Q1 2012 mediwatch.com Mediwatch USA Inc 1501 Northpoint Parkway - Suite 103 West Palm Beach - FL 33407 - USA Tel: 1-888-471-2611 - Fax: 1-866-871-8262 E-mail: [email protected] Mediwatch UK Ltd Lumonics House - Valley Drive - Rugby CV21 1TQ - UK Tel: +44 (0) 1788 547888 - Fax: +44 (0) 1788 536434 E-mail: [email protected] www.mediwatch.com